130 related articles for article (PubMed ID: 17243178)
21. [Analysis of genetic polymorphisms of thiopurine S-methyltransferase (TPMT) in Mexican pediatric patients with cancer].
Moreno-Guerrero SS; Ramírez-Pacheco A; Dorantes-Acosta EM; Medina-Sanson A
Rev Invest Clin; 2013; 65(2):156-64. PubMed ID: 23844534
[TBL] [Abstract][Full Text] [Related]
22. Structural characteristics determine the cause of the low enzyme activity of two thiopurine S-methyltransferase allelic variants: a biophysical characterization of TPMT*2 and TPMT*5.
Wennerstrand P; Dametto P; Hennig J; Klingstedt T; Skoglund K; Appell ML; Mårtensson LG
Biochemistry; 2012 Jul; 51(30):5912-20. PubMed ID: 22747506
[TBL] [Abstract][Full Text] [Related]
23. Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23.
Lindqvist M; Skoglund K; Karlgren A; Söderkvist P; Peterson C; Kidhall I; Almer S
Pharmacogenet Genomics; 2007 Oct; 17(10):891-5. PubMed ID: 17885628
[TBL] [Abstract][Full Text] [Related]
24. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
[TBL] [Abstract][Full Text] [Related]
25. Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.
Otterness DM; Szumlanski CL; Wood TC; Weinshilboum RM
J Clin Invest; 1998 Mar; 101(5):1036-44. PubMed ID: 9486974
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism of thiopurine S-methyltransferase in Argentina.
Laróvere LE; de Kremer RD; Lambooy LH; De Abreu RA
Ann Clin Biochem; 2003 Jul; 40(Pt 4):388-93. PubMed ID: 12880540
[TBL] [Abstract][Full Text] [Related]
27. Rapid genotyping of common deficient thiopurine S-methyltransferase alleles using the DNA-microchip technique.
Nasedkina TV; Fedorova OE; Glotov AS; Chupova NV; Samochatova EV; Maiorova OA; Zemlyakova VV; Roudneva AE; Chudinov AV; Yurasov RA; Kozhekbaeva JM; Barsky VE; Krynetskiy EY; Krynetskaia NF; Cheng C; Ribeiro RC; Evans WE; Roumyantsev AG; Zasedatelev AS
Eur J Hum Genet; 2006 Sep; 14(9):991-8. PubMed ID: 16724002
[TBL] [Abstract][Full Text] [Related]
28. Insight into TPMT(∗)23 mutation mis-folding using molecular dynamics simulation and protein structure analysis.
Larif S; Ben Salem C; Soua Z; Hmouda H; Bouraoui K
J Biomol Struct Dyn; 2013 Oct; 31(10):1066-76. PubMed ID: 23025308
[TBL] [Abstract][Full Text] [Related]
29. Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme function.
Schaeffeler E; Eichelbaum M; Reinisch W; Zanger UM; Schwab M
Hum Mutat; 2006 Sep; 27(9):976. PubMed ID: 16917910
[TBL] [Abstract][Full Text] [Related]
30. Frequency of the thiopurine S-methyltransferase alleles in the ancient genetic population isolate of Sardinia.
Rossino R; Vincis C; Alves S; Prata MJ; Macis MD; Nucaro AL; Schirru E; Congia M
J Clin Pharm Ther; 2006 Jun; 31(3):283-7. PubMed ID: 16789994
[TBL] [Abstract][Full Text] [Related]
31. Thiopurine S-methyltransferase genetic polymorphism in the Thai population.
Srimartpirom S; Tassaneeyakul W; Kukongviriyapan V; Tassaneeyakul W
Br J Clin Pharmacol; 2004 Jul; 58(1):66-70. PubMed ID: 15206995
[TBL] [Abstract][Full Text] [Related]
32. [Thiopurine S-methyltransferase gene polymorphism in Chilean blood donors].
Alvarez L L; Venegas S M; Larrondo L M; Becerra B N; Castro L A; Quera P R
Rev Med Chil; 2009 Feb; 137(2):185-92. PubMed ID: 19543639
[TBL] [Abstract][Full Text] [Related]
33. A structural basis for the preferential binding of hemimethylated DNA by HhaI DNA methyltransferase.
O'Gara M; Roberts RJ; Cheng X
J Mol Biol; 1996 Nov; 263(4):597-606. PubMed ID: 8918941
[TBL] [Abstract][Full Text] [Related]
34. Structural and functional impact of missense mutations in TPMT: An integrated computational approach.
Fazel-Najafabadi E; Vahdat Ahar E; Fattahpour S; Sedghi M
Comput Biol Chem; 2015 Dec; 59 Pt A():48-55. PubMed ID: 26410243
[TBL] [Abstract][Full Text] [Related]
35. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity.
Tai HL; Krynetski EY; Schuetz EG; Yanishevski Y; Evans WE
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6444-9. PubMed ID: 9177237
[TBL] [Abstract][Full Text] [Related]
36. A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations.
Roberts RL; Barclay ML; Gearry RB; Kennedy MA
Clin Chim Acta; 2004 Mar; 341(1-2):49-53. PubMed ID: 14967158
[TBL] [Abstract][Full Text] [Related]
37. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
38. Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations.
Lee SS; Kim WY; Jang YJ; Shin JG
Clin Chim Acta; 2008 Dec; 398(1-2):82-5. PubMed ID: 18775689
[TBL] [Abstract][Full Text] [Related]
39. Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*16 and TPMT*19.
Hamdan-Khalil R; Gala JL; Allorge D; Lo-Guidice JM; Horsmans Y; Houdret N; Broly F
Biochem Pharmacol; 2005 Feb; 69(3):525-9. PubMed ID: 15652243
[TBL] [Abstract][Full Text] [Related]
40. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.
Wang L; Nguyen TV; McLaughlin RW; Sikkink LA; Ramirez-Alvarado M; Weinshilboum RM
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9394-9. PubMed ID: 15967990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
